Neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a comparative cohort study
Keywords:
Intralesional methotrexate (MTX-il)
Neoadjuvant therapy for keratoacanthoma
Cutaneous squamous cell carcinoma as neoadjuvant therapy (cSCC)
Citation:
Salido-Vallejo, R. (Rafael); Cuevas-Asencio, I. (I.); Garnacho-Sucedo, G. (G.); et al. "Neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a comparative cohort study". European Academy of Dermatology and Venereology. 30 (7), 2015, 1120 - 1124
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.